IfPA’s Patient Access Policy Blog

New IfPA Paper: Why Doctors Need to Know When Pharmacists Substitute Biological Medicines

Today the Institute for Patient Access released a new policy brief entitled “WHY DOCTORS NEED TO KNOW WHEN PHARMACISTS SUBSTITUTE BIOLOGICAL MEDICINES.” In this edition of IfPA’s “The Physician’s Perspective,” David Charles, M.D. and Mary Ann Chapman, PhD succinctly set forward the benefits of physician notice and rebut the arguments against physician notice. You can read the policy brief here.

Back to Top